Oct 26, 2026 04:00PM
Oct 8, 2026 03:00PM
Oct 8, 2026 08:30AM
Oct 8, 2026 02:30AM
Oct 8, 2026 02:30AM
Sep 28, 2026 08:00AM
Sep 28, 2026 08:00AM U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® (elinzanetant) for a New Indication for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Endocrine Therapy Related
Sep 17, 2026 02:30AM
Sep 17, 2026 02:30AM
Sep 9, 2026 10:22PM
Sep 9, 2026 10:21PM
Aug 30, 2026 07:45AM
Aug 20, 2026 08:00AM
Jul 28, 2026 08:00AM One A Day® Introduces New Women's Multi Gummy Formula with 1,000 mcg Biotin
Jul 2, 2026 08:00AM
Jun 15, 2026 02:30AM
Jun 15, 2026 02:30AM
Jun 5, 2026 06:41AM
Jun 5, 2026 06:40AM
Jun 2, 2026 08:00AM
May 21, 2026 08:00AM Bayer to present cancer trial data at ASCO 2026 meeting
May 21, 2026 08:00AM
May 21, 2026 02:30AM
May 21, 2026 02:30AM
May 19, 2026 02:30AM
May 19, 2026 02:30AM
May 18, 2026 08:41AM
May 18, 2026 08:41AM U.S. FDA Grants Priority Review to Supplemental New Drug Application for HYRNUO® (sevabertinib) Under Investigation as a First-Line Treatment of HER2-Mutated Non-Small Cell Lung Cancer
May 7, 2026 02:30AM
Apr 28, 2026 02:23AM
Mar 26, 2026 09:55AM
Mar 16, 2026 03:30AM
Mar 4, 2026 08:00AM
Mar 4, 2026 08:00AM
Feb 23, 2026 10:28AM Bayer Alleges J&J’s Claims Regarding NUBEQA® are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J’s ERLEADA
Feb 5, 2026 12:15PM
Feb 5, 2026 12:15PM
Jan 29, 2026 08:30AM
Jan 13, 2026 02:15PM
Jan 13, 2026 09:00AM
Jan 12, 2026 08:00AM
Dec 4, 2025 02:30AM Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome
Dec 2, 2025 08:05AM
Dec 1, 2025 11:30AM
Nov 23, 2025 11:28AM
Nov 20, 2025 08:00AM
Nov 20, 2025 08:00AM
Nov 6, 2025 09:00AM
Oct 24, 2025 01:25PM Bayer receives FDA approval for Lynkuet menopause hot flash treatment
Oct 24, 2025 01:25PM

335,393 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All